Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD
Clinical trial NCT04626128 · COMPLETED
Trial details
- NCT number
- NCT04626128
- Sponsor
- Clearside Biomedical, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2022-10-13
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.